[go: up one dir, main page]

EE9900588A - CD154 blokaadravi pankreasesaarte koe transplantatsiooni korral - Google Patents

CD154 blokaadravi pankreasesaarte koe transplantatsiooni korral

Info

Publication number
EE9900588A
EE9900588A EEP199900588A EEP9900588A EE9900588A EE 9900588 A EE9900588 A EE 9900588A EE P199900588 A EEP199900588 A EE P199900588A EE P9900588 A EEP9900588 A EE P9900588A EE 9900588 A EE9900588 A EE 9900588A
Authority
EE
Estonia
Prior art keywords
graft
compositions
methods
blockade
insulin
Prior art date
Application number
EEP199900588A
Other languages
English (en)
Inventor
S. Kenyon Norma
Ricordi Camillo
W. Thomas David
Burkly Linda
Original Assignee
Biogen, Incorporated
University Of Miami
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biogen, Incorporated, University Of Miami filed Critical Biogen, Incorporated
Publication of EE9900588A publication Critical patent/EE9900588A/et

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2875—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the NGF/TNF superfamily, e.g. CD70, CD95L, CD153, CD154
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Mycology (AREA)
  • Transplantation (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • External Artificial Organs (AREA)
  • Steroid Compounds (AREA)
EEP199900588A 1997-06-20 1998-06-19 CD154 blokaadravi pankreasesaarte koe transplantatsiooni korral EE9900588A (et)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US5026797P 1997-06-20 1997-06-20
US7726598P 1998-03-09 1998-03-09
PCT/US1998/012892 WO1998058669A2 (en) 1997-06-20 1998-06-19 Cd154 blockade therapy for pancreatic islet tissue transplantation

Publications (1)

Publication Number Publication Date
EE9900588A true EE9900588A (et) 2000-08-15

Family

ID=26728084

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP199900588A EE9900588A (et) 1997-06-20 1998-06-19 CD154 blokaadravi pankreasesaarte koe transplantatsiooni korral

Country Status (21)

Country Link
US (2) US20030072754A1 (et)
EP (1) EP1051191B1 (et)
JP (1) JP2002506446A (et)
KR (1) KR100634847B1 (et)
CN (2) CN1651919A (et)
AT (1) ATE339966T1 (et)
AU (1) AU730763B2 (et)
BG (1) BG64976B1 (et)
BR (1) BR9810620A (et)
CA (1) CA2294154A1 (et)
DE (1) DE69835965T2 (et)
EA (1) EA002550B1 (et)
EE (1) EE9900588A (et)
HU (1) HUP0003160A3 (et)
IL (1) IL133303A0 (et)
IS (1) IS5273A (et)
NO (1) NO996275L (et)
NZ (1) NZ502052A (et)
SK (1) SK180299A3 (et)
TR (1) TR199903142T2 (et)
WO (1) WO1998058669A2 (et)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999045958A1 (en) * 1998-03-09 1999-09-16 Biogen, Inc. Cd154 blockade therapy for modulation of immune responses to implanted devices
AU2001251612A1 (en) 2000-04-14 2001-10-30 Millennium Pharmaceuticals, Inc. Roles of jak/stat family members in tolerance induction
CA2410786A1 (en) * 2000-06-02 2001-12-13 Regents Of The University Of Minnesota Immunotherapeutic method to prevent islet cell rejection
MXPA02012157A (es) * 2000-06-09 2003-06-06 Bristol Myers Squibb Co Metodos para regular una respuesta inmune mediada por celulas al bloquear se°ales linfociticas y al bloquear la adhesion mediada por el antigeno 1 asociado con la funcion de linfocitos.
NZ544486A (en) * 2003-06-13 2009-04-30 Biogen Idec Inc Aglycosyl anti-cd154 (cd40 ligand) antibodies and uses thereof
JP5102028B2 (ja) 2004-07-26 2012-12-19 バイオジェン・アイデック・エムエイ・インコーポレイテッド 抗ｃｄ１５４抗体
US8039254B2 (en) * 2004-11-22 2011-10-18 Ramot At Tel-Aviv University Ltd. Populations of expanded and re-differentiated adult islet beta cells capable of producing insulin and methods of generating same
US20070087029A1 (en) * 2005-10-14 2007-04-19 Pakala Syamasundar V Localized delivery to the lymphatic system
US8372399B2 (en) 2006-08-31 2013-02-12 Cardiac Pacemakers, Inc. Bispecific antibodies and agents to enhance stem cell homing
US8636995B2 (en) 2006-08-31 2014-01-28 Cardiac Pacemakers, Inc. Methods and devices to regulate stem cell homing
EP2396348B1 (en) 2009-02-10 2015-04-08 The Trustees of Columbia University in the City of New York Compositions comprising hla-e for use in methods for inducing transplantation tolerance
WO2011146395A2 (en) 2010-05-17 2011-11-24 The Board Of Trustees Of The Leland Stanford Junior University Prevention of immunological rejection of transplanted stem cells by leukocyte costimulatory molecule blockade
GB201403775D0 (en) 2014-03-04 2014-04-16 Kymab Ltd Antibodies, uses & methods
US10147463B2 (en) 2014-12-10 2018-12-04 Nxp Usa, Inc. Video processing unit and method of buffering a source video stream
US9512229B2 (en) 2015-03-03 2016-12-06 Kymab Limited Synergistic combinations of OX40L antibodies for the treatment of GVHD
KR101810778B1 (ko) * 2015-06-23 2017-12-20 서울대학교산학협력단 Cd154 결합 폴리펩타이드 및 그 용도
US10986309B2 (en) 2015-06-30 2021-04-20 Nxp Usa, Inc. Video buffering and frame rate doubling device and method
JP7461741B2 (ja) 2016-06-20 2024-04-04 カイマブ・リミテッド 抗ｐｄ－ｌ１およびｉｌ－２サイトカイン
EP3534947A1 (en) 2016-11-03 2019-09-11 Kymab Limited Antibodies, combinations comprising antibodies, biomarkers, uses & methods
KR20210095781A (ko) 2020-01-24 2021-08-03 주식회사 에이프릴바이오 항원결합 단편 및 생리활성 이펙터 모이어티로 구성된 융합 컨스트럭트를 포함하는 다중결합항체 및 이를 포함하는 약학조성물

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5227298A (en) * 1990-08-17 1993-07-13 The Trustees Of Columbia University In The City Of New York Method for microencapuslation of cells or tissue
US5474771A (en) * 1991-11-15 1995-12-12 The Trustees Of Columbia University In The City Of New York Murine monoclonal antibody (5c8) recognizes a human glycoprotein on the surface of T-lymphocytes, compositions containing same
US5683693A (en) * 1994-04-25 1997-11-04 Trustees Of Dartmouth College Method for inducing T cell unresponsiveness to a tissue or organ graft with anti-CD40 ligand antibody or soluble CD40
IL125928A (en) * 1996-03-20 2002-11-10 Bristol Myers Squibb Co The use of soluble ligands that react with CTLA4, B7, CD40, gp39 and / or CD28 for the preparation of pharmaceutical preparations

Also Published As

Publication number Publication date
CA2294154A1 (en) 1998-12-30
CN1195546C (zh) 2005-04-06
DE69835965D1 (de) 2006-11-02
JP2002506446A (ja) 2002-02-26
HUP0003160A2 (hu) 2001-01-29
KR20010013965A (ko) 2001-02-26
NZ502052A (en) 2001-01-26
EP1051191A2 (en) 2000-11-15
WO1998058669A2 (en) 1998-12-30
IS5273A (is) 1999-11-26
US20030072754A1 (en) 2003-04-17
WO1998058669A3 (en) 1999-04-29
CN1261286A (zh) 2000-07-26
EP1051191B1 (en) 2006-09-20
KR100634847B1 (ko) 2006-10-17
HUP0003160A3 (en) 2002-09-30
IL133303A0 (en) 2001-04-30
DE69835965T2 (de) 2007-06-14
BR9810620A (pt) 2000-10-03
AU7983098A (en) 1999-01-04
CN1651919A (zh) 2005-08-10
TR199903142T2 (xx) 2000-09-21
EA002550B1 (ru) 2002-06-27
NO996275L (no) 2000-02-21
SK180299A3 (en) 2000-06-12
BG104091A (en) 2000-10-31
ATE339966T1 (de) 2006-10-15
US20070292440A1 (en) 2007-12-20
AU730763B2 (en) 2001-03-15
BG64976B1 (bg) 2006-11-30
NO996275D0 (no) 1999-12-17
HK1033548A1 (en) 2001-09-07
EA200000058A1 (ru) 2000-08-28

Similar Documents

Publication Publication Date Title
EE9900588A (et) CD154 blokaadravi pankreasesaarte koe transplantatsiooni korral
JP2003277293A5 (et)
CA2320040A1 (en) Mesenchymal stem cells for prevention and treatment of immune responses in transplantation
DK1220611T3 (da) Suppressorceller til forebyggelse og behandling af immunreaktioner ved transplantation
ZA853690B (en) Immunoregulation
WO2003102162A3 (en) Novel tolerogenic dendritic cells and therapeutic uses therefor
WO1993006852A3 (en) Methods of improving allograft or xenograft tolerance by administration of an lfa-3 or cd2 binding protein
WO2002017935A3 (en) A method of transplantation using chemotherapy-treated allogeneic cells that enhance immune responses without graft versus host disease
FI941552A0 (fi) Gamma-INF:n käyttö infektioiden hoitoon siirrännäisten saajilla
IL95046A0 (en) Substituted 2-imidazolines and pharmaceutical compositions containing them
ES2108122T3 (es) Composicion a base de amilina o de un analogo de amilina conteniendo opcionalmente insulina, para el tratamiento de la anorexia y de las patologias asociadas.
IL131478A0 (en) Methods for treatment of scar tissue
EP1754490A3 (en) CD 154 blockage therapy for pancreatic islet tissue transplantation in primates
HU9202026D0 (en) Method and medical preparative for treatment of thrombocytopenie
MXPA02011592A (es) Composiciones de celulas dendriticas circulantes, humanas y metodos.
DE69231583D1 (de) Zusammensetzung zur Behandlung des Insulinmangels bei Säugetieren, die Amylin und Insulin enthält.
DK1370641T3 (da) Anvendelse af stamceller og CD6-depleterede stamceller til toleransinduktion i forhold til allogene transplantater og/eller leukæmibehandling
UA32295A (uk) Спосіб лікування порушень фертильності у хворих на цукровий діабет
EP0886528A4 (en) USE OF COXIELLA BACTERIA TO TREAT AUTOIMMUNE DISEASES
CA2402489A1 (en) Oral tolerance induction by collagen to prevent allograft rejection
NO20016326L (no) Anvendelse av proteinet UK 114 for å hindre avstötning av organtransplantatet
Vigne The replacement of the small mammal fauna of Corsica, at the arrival time of man.).
IL117734A (en) Anellated beta-carbolines their preparation and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
HC1A Change of owner name